The conference organized by ECCN, under the auspices of the European Association of Nuclear Medicine (EANM) gather international physicians and researches of PET imaging modalities to review some of the major aspects of neuroimaging in neurology and studying new research perspectives in these fields.
The use of biomarkers and the innovations in radiotracers more specifics for brain imaging has focused several lectures and oral presentations. Also, the PET imaging applications to diagnose diseases accurately such as Alzheimer’s, epilepsy, Parkinson’s, brain tumors and other disorders. We would like to highlight the oral presentation of Prof. A. Lammertsma (Netherlands) who review the evolution of the image quantification in clinical PET.
Oncovision joined the conference in order to strength and develop its study line on brain molecular imaging with the dedicated PET CareMiBrain.